xCas9(3.7)-BE4 Citations (4)

Originally described in: Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
Hu JH, Miller SM, Geurts MH, Tang W, Chen L, Sun N, Zeina CM, Gao X, Rees HA, Lin Z, Liu DR Nature. 2018 Feb 28. pii: nature26155. doi: 10.1038/nature26155. PubMed Journal

---

Articles Citing xCas9(3.7)-BE4

Articles
Base editing-mediated one-step inactivation of the Dnmt gene family reveals critical roles of DNA methylation during mouse gastrulation. Li Q, Lu J, Yin X, Chang Y, Wang C, Yan M, Feng L, Cheng Y, Gao Y, Xu B, Zhang Y, Wang Y, Cui G, Xu L, Sun Y, Zeng R, Li Y, Jing N, Xu GL, Wu L, Tang F, Li J. Nat Commun. 2023 May 22;14(1):2922. doi: 10.1038/s41467-023-38528-z. PubMed
Selective haematological cancer eradication with preserved haematopoiesis. Garaude S, Marone R, Lepore R, Devaux A, Beerlage A, Seyres D, Dell' Aglio A, Juskevicius D, Zuin J, Burgold T, Wang S, Katta V, Manquen G, Li Y, Larrue C, Camus A, Durzynska I, Wellinger LC, Kirby I, Van Berkel PH, Kunz C, Tamburini J, Bertoni F, Widmer CC, Tsai SQ, Simonetta F, Urlinger S, Jeker LT. Nature. 2024 Jun;630(8017):728-735. doi: 10.1038/s41586-024-07456-3. Epub 2024 May 22. PubMed
Evidence That a Peptide-Drug/p53 Gene Complex Promotes Cognate Gene Expression and Inhibits the Viability of Glioblastoma Cells. Neves A, Albuquerque T, Faria R, Santos CRA, Vives E, Boisguerin P, Carneiro D, Bruno DF, Pavlaki MD, Loureiro S, Sousa A, Costa D. Pharmaceutics. 2024 Jun 8;16(6):781. doi: 10.3390/pharmaceutics16060781. PubMed
Functional evaluation of germline TP53 variants identified in Brazilian families at-risk for Li-Fraumeni syndrome. Abreu RBV, Pereira AS, Rosa MN, Ashton-Prolla P, Silva VAO, Melendez ME, Palmero EI. Sci Rep. 2024 Jul 26;14(1):17187. doi: 10.1038/s41598-024-67810-3. PubMed

If you have published an article using this material, please email us at to have your article added to this page.